Pune: Garware Fulflex has announced the successful completion of its acquisition of a 300,000-square-foot, fully automated medical products manufacturing facility in Jacksonville, Texas.
The acquisition marks a significant milestone in Garware Fulflex’s global healthcare growth strategy while substantially expanding its manufacturing footprint across North America.
Located on a 30-acre campus, the Jacksonville facility employs more than 250 people and manufactures a wide range of critical medical products used by healthcare providers and patients across North America and other global markets.
The facility is equipped with advanced manufacturing technologies, including injection molding, blow molding, thermoforming, extrusion, assembly, and quality systems.
These capabilities further strengthen Garware Fulflex’s ability to support leading global healthcare companies with world-class medical manufacturing solutions.
The acquisition is expected to double Garware Fulflex’s global revenue from approximately US$100 million to US$200 million.
It also significantly expands the company’s manufacturing scale and strengthens its position as a global healthcare manufacturing company.
Also Read: Kapture CX Secures USD 10 Mn Pre-Series B Funding Led by Bajaj Finserv Ventures
“This acquisition represents a defining milestone in our journey to build a globally respected healthcare manufacturing company,” said Diya Garware Ibanez, Chairperson of Garware Fulflex.
“The Jacksonville facility brings exceptional people, world-class manufacturing capabilities, and an important presence in the world’s largest healthcare market.
Most importantly, we are proud to welcome more than 250 talented employees to the Fulflex family. Together, we will continue delivering high-quality medical products while investing in innovation, operational excellence, and long-term growth.”
With the addition of the Jacksonville facility, Garware Fulflex further strengthens its global manufacturing network by increasing production capacity, enhancing technical expertise, improving supply chain resilience, and expanding its proximity to customers in the North American healthcare market.
The acquisition adds another strategic manufacturing hub to Garware Fulflex’s expanding global operations, reinforcing its commitment to serving healthcare companies with advanced manufacturing capabilities and high-quality medical products.
About Garware Fulflex
Garware Fulflex is a global healthcare manufacturing company specializing in medical products and engineered polymer solutions. Headquartered in India, the company develops and manufactures products used in medical devices, healthcare, rehabilitation, personal protective equipment (PPE), and other specialized healthcare applications.
Following the acquisition, Garware Fulflex operates 14 locations worldwide, including four manufacturing facilities in the United States, one manufacturing facility in the Dominican Republic, two manufacturing facilities in India, and seven sales offices and distribution centers.
Its global network serves customers in more than 85 countries, delivering innovative healthcare products and engineered polymer solutions to some of the world’s leading medical companies.
